Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hazard Rate01:11

Hazard Rate

476
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
476
Hazard Ratio01:12

Hazard Ratio

688
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
688
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

932
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
932
Contingency Table01:29

Contingency Table

4.8K
A contingency table provides a way of portraying data that can facilitate calculating probabilities. It is a method of displaying a frequency distribution as a table with rows and columns to show how two variables may be dependent (contingent) upon each other; The table helps determine conditional probabilities quite quickly and can help systematically organize, analyze and quantify data. The table displays sample values concerning two variables that may be dependent or contingent on one...
4.8K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

482
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
482
Censoring Survival Data01:09

Censoring Survival Data

630
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
630

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomaterial-mediated scavenging of extracellular thrombospondin-1 in peripheral vessels mitigates intestinal ischemia-reperfusion injury.

Acta biomaterialia·2026
Same author

Chirality of poly(γ-glutamic acid) directs calcium nanoparticle assembly and adjuvant-like immune activation.

Acta biomaterialia·2026
Same author

Maleimide-Modified PEG-PLGA Nanoparticles Facilitate Gut Immune Tolerance via si<i>CD40</i> Delivery to Dendritic Cells for the Treatment of Inflammatory Bowel Disease.

ACS applied materials & interfaces·2026
Same author

Real-Time Target-Oriented Grasping Framework for Resource-Constrained Robots.

Sensors (Basel, Switzerland)·2026
Same author

Progress in anti-biofouling materials and coatings for the marine environment.

Journal of environmental sciences (China)·2025
Same author

Silica Aerogels in Nano Drug Delivery Systems: A Comprehensive Review from Preparation to Medical Applications.

Gels (Basel, Switzerland)·2025
Same journal

Shared frailty sieve estimation for dependent left truncated and interval censored data.

Lifetime data analysis·2026
Same journal

Functional win-fractions regression models for composite outcomes.

Lifetime data analysis·2026
Same journal

Variable selection in causal semiparametric transformation models with all-or-nothing treatment compliance.

Lifetime data analysis·2026
Same journal

Correction to: A uniformisation-driven algorithm for inference-related estimation of a phase-type ageing model.

Lifetime data analysis·2026
Same journal

Unobserved heterogeneity in threshold regression based on the hitting times of a reflected Brownian motion for recurrent hypoglycemia.

Lifetime data analysis·2026
Same journal

Variable selection with broken adaptive ridge regression for interval-censored competing risks data.

Lifetime data analysis·2026
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Mark-specific additive hazards regression with continuous marks.

Dongxiao Han1, Liuquan Sun2, Yanqing Sun3

  • 1Institute of Applied Mathematics, Chinese Academy of Sciences, Beijing, 100190, China.

Lifetime Data Analysis
|May 13, 2016
PubMed
Summary
This summary is machine-generated.

This study introduces a new mark-specific additive hazards model for survival data. It investigates the relationship between failure time and mark variables, offering insights into treatment effects in clinical trials.

Keywords:
Additive hazards modelCompeting risksConfidence bands and testsContinuous markHIV vaccine trialMark-specific vaccine effectsSurvival data

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Related Experiment Videos

Last Updated: Mar 21, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Epidemiology

Background:

  • Survival data analysis often involves mark variables observed only at failure times.
  • The additive hazards model, focusing on hazard differences, is a practical tool for analyzing such data.
  • Investigating the relationship between failure time and mark variables is crucial for understanding disease progression and treatment efficacy.

Purpose of the Study:

  • To propose a novel mark-specific additive hazards model.
  • To extend the additive hazards model to nonparametrically incorporate continuous mark variables.
  • To develop statistical methods for estimating model components and testing hypotheses related to mark-specific effects.

Main Methods:

  • Development of an estimating equation approach for regression function estimation.
  • Nonparametric modeling of regression coefficient functions and the baseline hazard function.
  • Asymptotic properties of the proposed estimators are theoretically established.
  • Construction of formal hypothesis tests for mark-specific treatment effects.

Main Results:

  • The proposed mark-specific additive hazards model effectively estimates regression functions.
  • Asymptotic properties of the estimators are rigorously derived.
  • Simulation studies demonstrate the finite sample performance of the estimators.
  • The model is applied to real-world data from an HIV vaccine efficacy trial.

Conclusions:

  • The developed mark-specific additive hazards model provides a flexible framework for survival data with mark variables.
  • The proposed methods offer reliable estimation and hypothesis testing for mark-specific effects.
  • The application to HIV vaccine trial data highlights the model's practical utility in biomedical research.